Top Markets
#1 PulseChain PulseChain +45.01%
#2 Glidr Glidr +20.14%
#3 Fake World Assets Fake World Assets +9.76%
#4 Ergo Ergo +9.25%
#5 eCash eCash +8.85%
#6 DeFi Kingdoms DeFi Kingdoms +8.68%
#7 Ribbita by Virtuals Ribbita by Virtuals +8.32%
#8 Meteora Meteora +8.28%
#9 Verus Coin Verus Coin +7.70%
#10 Cash Cat Cash Cat +7.22%
Coin of the day
PulseChain PulseChain
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Marinus Pharmaceuticals, Inc. Marinus Pharmaceuticals, Inc.

Marinus Pharmaceuticals, Inc.

MRNS
Classement en actions #28040
Marinus Pharmaceuticals, Inc. is a specialized biopharmaceutical firm dedicated... Marinus Pharmaceuticals, Inc. is a specialized biopharmaceutical firm dedicated to the development and commercialization of therapeutic solutions for individuals suffering from rare genetic epilepsies and other seizure-related conditions. The company's primary commercialized product is ZTALMY, an oral suspension specifically designed to manage seizures associated with cyclin-dependent kinase-like 5 deficiency disorder (CDD). This medication is prescribed for both adult and pediatric patient populations, suitable for use in acute and chronic care settings, and can be administered either in-patient or by the patient themselves. ZTALMY exerts its effect by targeting synaptic and extrasynaptic GABAA receptors, a mechanism that also suggests potential anticonvulsant, antidepressant, and anxiolytic benefits. Beyond ZTALMY, Marinus is actively progressing ganaxolone through development, an investigational therapy aimed at various genetic epileptic conditions such as PCDH19-related epilepsy, tuberous sclerosis complex, and Lennox-Gastaut Syndrome, with additional exploration for depressive disorders. The company maintains strategic alliances, including licensing agreements with Purdue Neuroscience Company and CyDex Pharmaceuticals, Inc., as well as a collaborative partnership with Orion Corporation. Marinus Pharmaceuticals was established in 2003 and operates from its corporate headquarters in Radnor, Pennsylvania.
Prix de l'action
$0.55
Dernière synchronisation: 2025-02-11
Capitalisation boursière
$28.90M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Marinus Pharmaceuticals, Inc. (MRNS)

Catégorie

Healthcare
Le prix MRNS avec la capitalisation boursière de B
Marinus Pharmaceuticals, Inc. Marinus Pharmaceuticals, Inc.
MRNS
$0.55
Capitalisation boursière de Marinus Pharmaceuticals, Inc.(MRNS)
Capitalisation boursière: $28.90M
En August 2026, Marinus Pharmaceuticals, Inc. a une capitalisation boursière de $28.90M. Cela fait de Marinus Pharmaceuticals, Inc. la 28040th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Marinus Pharmaceuticals, Inc. du 2014 au 2026
MRNS par rapport au top 5 des plus populaires stocks
Prix pour MRNS L’actif B La capitalisation boursière de B Résultats
Marinus Pharmaceuticals, Inc. Marinus Pharmaceuticals, Inc.
$100,863 $28.90M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.301T +18,338,556.47%
Marinus Pharmaceuticals, Inc. Marinus Pharmaceuticals, Inc.
$88,171.23 $28.90M
Apple Inc. Apple Inc.
AAPL
$4.634T +16,031,032.11%
Marinus Pharmaceuticals, Inc. Marinus Pharmaceuticals, Inc.
$78,830.84 $28.90M
Alphabet Inc. Alphabet Inc.
GOOG
$4.143T +14,332,779.38%
Marinus Pharmaceuticals, Inc. Marinus Pharmaceuticals, Inc.
$68,297.02 $28.90M
Microsoft Corporation Microsoft Corporation
MSFT
$3.589T +12,417,540.68%
Marinus Pharmaceuticals, Inc. Marinus Pharmaceuticals, Inc.
$54,360.78 $28.90M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.857T +9,883,677.47%